Mitchell S Cairo, MD
New York Medical College · Columbia University · Morgan Stanley Childrens Hospital of New York Presbyterian, Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mitchell S Cairo, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:14 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07013565 · Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCLNew York Medical College · recruiting · Anaplastic Large Cell Lymphoma, ALK-Positive · principal investigator
- Ph1/Ph2NCT06617286 · CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin LymphomaNew York Medical College · not yet recruiting · Classical Hodgkin Lymphoma · principal investigator
- Ph1/Ph2NCT04896606 · SARS-CoV-2 CTLS for Mild to Moderate COVID-19 DiseaseNew York Medical College · recruiting · Covid19 · study chair
- Ph2NCT04777422 · Defibrotide in Children With High Risk Kawasaki DiseaseNew York Medical College · unknown · Kawasaki Disease · principal investigator
- Ph1/Ph2NCT04197596 · Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)New York Medical College · recruiting · Viral Infection, Primary Immune Deficiency Disorder · principal investigator
- Ph2NCT03805581 · Defibrotide in Sickle Cell Disease-Related Acute Chest SyndromeNew York Medical College · completed · Sickle Cell Disease, Acute Chest Syndrome · principal investigator
- Ph2NCT03266640 · Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)New York Medical College · recruiting · Cytomegalovirus Infections, Primary Immune Deficiency Disorder · principal investigator
- Ph2NCT02434965 · Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic EncephalopathyNew York Medical College · withdrawn · Severe Hypoxic-ischemic Encephalopathy · principal investigator
- Ph2NCT02221310 · Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDSNew York Medical College · completed · Acute Myelogenous Leukemia, Myelodysplastic Syndrome · principal investigator
- Ph2NCT01859819 · Treatment for Advanced B-Cell LymphomaNew York Medical College · completed · Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma · principal investigator
- Ph2NCT01636388 · Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins LymphomaNew York Medical College · terminated · Hodgkins Lymphoma · principal investigator
- Ph1NCT01586455 · Human Placental-Derived Stem Cell TransplantationNew York Medical College · completed · Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy · principal investigator
- Ph2NCT01461837 · Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell DiseaseNew York Medical College · active not recruiting · Sickle Cell Disease · principal investigator
- Ph2NCT01050439 · Unrelated Donor Transplant for Malignant and Non-Malignant DisordersColumbia University · terminated · Leukemia, Lymphoma, Bone Marrow Failure Syndromes · principal investigator
- Ph2NCT01049854 · CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor TransplantNew York Medical College · completed · Leukemia, Lymphoma, Bone Marrow Failure · principal investigator
- Ph2NCT00801918 · Denileukine Diftitox for Relapsed ALCLColumbia University · withdrawn · Anaplastic Large-Cell Lymphoma · principal investigator
- Ph1NCT00669890 · Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMMLNew York Medical College · terminated · Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome · study chair
- Ph3NCT00162656 · Treatment of Mature B-cell Lymphoma/LeukaemiaGustave Roussy, Cancer Campus, Grand Paris · completed · B-Cell Lymphoma · principal investigator
- Ph1NCT00003597 · Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsChildren's Oncology Group · completed · Cancer · study chair
- Ph3NCT00002757 · TITLE:Less Intensive Therapy for Children With Non-Hodgkin's LymphomaChildren's Oncology Group · completed · Leukemia, Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.